Association of the COVID-19 Pandemic on Treatment Times for ST-Elevation Myocardial Infarction: Observations from the Los Angeles County Regional System.
The American journal of cardiology · 2023-11-26 · Observational study
Abstract
Previous studies have documented longer treatment times and worse outcomes for patients with ST-elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PCI) during the COVID-19 pandemic. The objective of the present study was to evaluate the impact of the COVID-19 pandemic on treatment times and outcomes for patients with STEMI who underwent primary PCI within a regional system of care. This was a retrospective study using data from the Los Angeles County Emergency Medical Services Agency. Data on the emergency medical service activations were abstracted for patients with STEMI from March 19, 2020 to January 31, 2021, during the COVID-19 pandemic and for the same interval the previous year. All adult patients (≥18 years) with STEMI who underwent emergent coronary angiography were included. The primary end point was the first medical contact (FMC) to device time. The secondary end points included treatment time intervals, vascular complications, need for emergent coronary artery bypass surgery, length of hospital stay, and in-hospital mortality. During the study period, 3,017 patients underwent coronary angiography for STEMI, 1,893 patients pre-COVID-19 and 1,124 patients during COVID-19 (40% lower). A total of 2,334 patients (77%) underwent PCI. During the COVID-19 period, rates of PCI were significantly lower compared with the control period (75.1% vs 78.7%, p = 0.02). FMC to device time was shorter during the COVID-19 period compared with the control period (median 77.0 vs 81.0 minutes, p = 0.004). For patients with STEMI complicated by out-of-hospital cardiac arrest, FMC to device time was similar during the COVID-19 period compared with the control period (median 95.0 [33.0] vs 100.0 [40.0] minutes, p = 0.34). Vascular complications, the need for emergent bypass surgery, length of hospital stay, and in-hospital mortality were similar between the periods. In conclusion, in this large regional system of care, we found a relatively small but significant decrease in treatment times, yet overall, similar clinical outcomes for patients with STEMI who underwent primary PCI and were treated during the COVID-19 period compared with a control period. These findings suggest that mature cardiac systems of care were able to maintain efficient care despite the challenges of the COVID-19 pandemic.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
COVID-19 pandemic · Time intervals
Related articles
- Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: A systematic review and meta-analysis. (Indian Heart J, 2021)
- Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis. (Heart, 2020)
- Impact of COVID-Era Emergency Department Bypass Suspension on ST-Segment Elevation Myocardial Infarction System Performance in Rural Practice. (Crit Pathw Cardiol, 2026)
- Effect of prehospital 12-Lead electrocardiography on the emergent medical system for ST-Segment-Elevation myocardial infarction during the coronavirus disease 2019 (COVID-19) pandemic: results from the K-ACTIVE registry. (Cardiovasc Interv Ther, 2026)
- Social and clinical vulnerability in stroke and STEMI management during the COVID-19 pandemic: a registry-based study. (BMJ Open, 2024)
- Impact of COVID-19 pandemic on emergency medical system and management strategies in patients with acute coronary syndrome. (Sci Rep, 2023)